177 related articles for article (PubMed ID: 37993439)
1. Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis.
James EA; Holers VM; Iyer R; Prideaux EB; Rao NL; Rims C; Muir VS; Posso SE; Bloom MS; Zia A; Elliott SE; Adamska JZ; Ai R; Brewer RC; Seifert JA; Moss L; Barzideh S; Demoruelle MK; Striebich CC; Okamoto Y; Sainbayar E; Crook AA; Peterson RA; Vanderlinden LA; Wang W; Boyle DL; Robinson WH; Buckner JH; Firestein GS; Deane KD
Nat Commun; 2023 Nov; 14(1):7637. PubMed ID: 37993439
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
3. Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis.
Hughes-Austin JM; Gan RW; Deane KD; Weisman MH; Demoruelle MK; Sokolove J; Robinson WH; Holers VM; Norris JM; Ix JH
Am J Nephrol; 2017; 46(6):481-487. PubMed ID: 29237149
[TBL] [Abstract][Full Text] [Related]
4. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
[TBL] [Abstract][Full Text] [Related]
5. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
7. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
[TBL] [Abstract][Full Text] [Related]
8. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis.
Bergstedt DT; Tarter WJ; Peterson RA; Feser ML; Parish MC; Striebich CC; Demoruelle MK; Moss L; Bemis EA; Norris JM; Holers VM; Edison JD; Thiele GM; Mikuls TR; Deane KD
Front Immunol; 2022; 13():916277. PubMed ID: 35812446
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to a Citrullinated
Sherina N; de Vries C; Kharlamova N; Sippl N; Jiang X; Brynedal B; Kindstedt E; Hansson M; Mathsson-Alm L; Israelsson L; Stålesen R; Saevarsdottir S; Holmdahl R; Hensvold A; Johannsen G; Eriksson K; Sallusto F; Catrina AI; Rönnelid J; Grönwall C; Yucel-Lindberg T; Alfredsson L; Klareskog L; Piccoli L; Malmström V; Amara K; Lundberg K
Front Immunol; 2022; 13():804822. PubMed ID: 35514991
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
[TBL] [Abstract][Full Text] [Related]
12. Bacterial citrullinated epitopes generated by
Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
[TBL] [Abstract][Full Text] [Related]
13. Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.
Glant TT; Ocsko T; Markovics A; Szekanecz Z; Katz RS; Rauch TA; Mikecz K
PLoS One; 2016; 11(3):e0150784. PubMed ID: 26943656
[TBL] [Abstract][Full Text] [Related]
14. Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis.
Umemoto A; Kuwada T; Murata K; Shiokawa M; Ota S; Murotani Y; Itamoto A; Nishitani K; Yoshitomi H; Fujii T; Onishi A; Onizawa H; Murakami K; Tanaka M; Ito H; Seno H; Morinobu A; Matsuda S
Arthritis Res Ther; 2023 Feb; 25(1):25. PubMed ID: 36804906
[TBL] [Abstract][Full Text] [Related]
15. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
16. CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.
Paulissen SM; van Hamburg JP; Davelaar N; Vroman H; Hazes JM; de Jong PH; Lubberts E
Arthritis Res Ther; 2015 Nov; 17():344. PubMed ID: 26617177
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
Meng X; Ezzati P; Smolik I; Bernstein CN; Hitchon CA; El-Gabalawy HS
PLoS One; 2016; 11(10):e0165501. PubMed ID: 27788229
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis.
Sonigra A; Nel HJ; Wehr P; Ramnoruth N; Patel S; van Schie KA; Bladen MW; Mehdi AM; Tesiram J; Talekar M; Rossjohn J; Reid HH; Stuurman FE; Roberts H; Vecchio P; Gourley I; Rigby M; Becart S; Toes RE; Scherer HU; Lê Cao KA; Campbell K; Thomas R
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36278483
[TBL] [Abstract][Full Text] [Related]
19. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
[TBL] [Abstract][Full Text] [Related]
20. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
